Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.

Onal, CemOymak, EzgiGuler, Ozan Cem2022-09-072022-09-0720211357-0560http://hdl.handle.net/11727/7577enginfo:eu-repo/semantics/closedAccessUpfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.Letter3870006605499000012-s2.0-85107585717